INM InMed Pharmaceuticals Inc.
Nasdaq · SEC CIK 1728328 · EDGAR
- Bought, last 12 months
- $1.27M 6 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 109 since 2021-09-29, latest 2026-09-16 18:58
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| ADAR1 Capital Management, LLC | 10% | $841.2K | — |
| Vivo Opportunity, LLC | 10% | $433.5K | — |
Transactions 18
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-09-16 18:58 | 2026-09-14+ | INM | ADAR1 Capital Management, LLC | 10% | P - Purchase | $1.30 | +91.1K | 892.1K | +11% | +$118.1K |
| I | 2026-07-17 19:29 | 2026-07-15 | INM | ADAR1 Capital Management, LLC | 10% | P - Purchase | $1.55 | +1,000 | 801.0K | +0.1% | +$1,555 |
| MI | 2026-07-16 21:58 | 2026-07-14+ | INM | Vivo Opportunity, LLC | 10% | P - Purchase | $1.55 | +20.5K | 75.0K | +38% | +$31.8K |
| MI | 2026-07-02 19:02 | 2026-06-30+ | INM | Vivo Opportunity, LLC | 10% | P - Purchase | $1.55 | +6,551 | 73.1K | +10% | +$10.1K |
| MI | 2026-06-10 21:14 | 2026-05-20+ | INM | Vivo Opportunity, LLC | 10% | P - Purchase | $1.57 | +249.2K | 72.5K | New | +$391.6K |
| MI | 2026-05-21 17:08 | 2026-05-19 | INM | ADAR1 Capital Management, LLC | 10% | P - Purchase | $1.54 | +468.6K | 800.0K | +141% | +$721.5K |
| 2024-08-02 | 2024-07-31 | INM | MANCINI ALEXANDRA DIANE JANET | Consultant | S - Sale | $0.18 | -240 | 0 | -100% | -$43.20 | |
| 2024-02-22 | 2024-02-21 | INM | HULL ANDREW | Dir | P - Purchase | $0.39 | +37.5K | 38.3K | +4,947% | +$14.6K | |
| 2024-02-21 | 2024-02-20 | INM | ADAMS ERIC A | Pres, CEO, Dir | P - Purchase | $0.36 | +41.6K | 44.0K | +1,763% | +$15.0K | |
| 2022-04-18 | 2022-04-14 | INM | ADAMS ERIC A | Pres, CEO, Dir | P - Purchase | $0.89 | +14.2K | 59.0K | +32% | +$12.6K | |
| 2022-04-13 | 2022-04-13 | INM | ADAMS ERIC A | Pres, CEO, Dir | P - Purchase | $0.85 | +8,560 | 44.8K | +24% | +$7,276 | |
| 2022-01-24 | 2022-01-24 | INM | COLWILL BRUCE | CFO | P - Purchase | $1.09 | +5,000 | 11.5K | +77% | +$5,450 | |
| 2022-01-06 | 2022-01-06 | INM | Johnson Shane Aaron | SVP, GM of BayMedica LLC | P - Purchase | $1.26 | +8,500 | 304.6K | +3% | +$10.7K | |
| 2021-12-30 | 2021-12-30 | INM | Johnson Shane Aaron | SVP, GM of BayMedica LLC | P - Purchase | $1.33 | +8,093 | 296.1K | +3% | +$10.8K | |
| 2021-11-15 | 2021-11-15 | INM | Johnson Shane Aaron | SVP, GM of BayMedica LLC | P - Purchase | $1.37 | +5,000 | 288.0K | +2% | +$6,850 | |
| 2021-09-30 | 2021-09-29 | INM | ADAMS ERIC A | Pres, CEO, Dir | P - Purchase | $1.73 | +8,800 | 36.3K | +32% | +$15.2K | |
| 2021-09-29 | 2021-09-28 | INM | COLWILL BRUCE | CFO | P - Purchase | $1.77 | +5,000 | 6,515 | +330% | +$8,850 | |
| 2021-09-29 | 2021-09-28 | INM | ADAMS ERIC A | Pres, CEO, Dir | P - Purchase | $1.75 | +11.4K | 27.5K | +71% | +$19.9K |
Purchase Sale Sale after option exercise All abbreviations